Prof.
Daniele Focosi
Azienda
Ospedaliero-Universitaria Pisana, Italy
Email: dfocosi@tin.it
Qualifications
2006 M.D., University of Pisa, Italy
Publications
(Selected)
-
Focosi
D, Galimberti S, Petrini M. Acute myeloid leukaemia and follicular lymphoma
after very low dose radioiodine therapy for thyroid diseases. Haematologica.
2007 Sep;92(9):e96-7
-
Focosi
D. Smoldering multiple myeloma. N Engl J Med. 2007 Sep 6;357(10):1048-9
-
Focosi
D, Caracciolo F, Galimberti S, Papineschi F, Petrini M. Long-term
propylthiouracil use and acute myeloid leukaemia : a case report and review of
the literature. Ann Hematol. 2008 Mar;87(3):233-5
-
Focosi
D, Kast RE, Petrini M. JC viremia and multiple sclerosis. J. Neurovirol. 2008
Jan;14(1):85-6
-
Focosi
D, Kast RE, Maggi F, Galimberti S, Ceccherini-Nelli L, Papineschi F, Petrini M.
Central nervous system graft-versus host disease : consider progressive
multifocal leukoencephalopathy among the differential diagnoses. Bone Marrow
Transplant. 2007 Dec;40(11):1095-6
-
Focosi
D, Kast RE, Benedetti E, Papineschi F, Galimberti S, Petrini M.
Phenobarbital-associated bone marrow aplasia: a case report and review of the literature.
Acta Haematol. 2008;119(1):18-21
-
Focosi
D, Caracciolo F, Galimberti S, Papineschi F, Petrini M.. False positive PET
scanning caused by inactivated influenza virus vaccination during complete
remission from anaplastic T-cell lymphoma. Ann Hematol. 2008 Apr;87(4):343-4
-
Focosi
D, Kast RE, Maggi F, Lauria G, Ceccherini-Nelli L, Petrini M. 5-HT(2a)
inhibitors for progressive multifocal leukoencephalopathy: old drugs for an old
disease . J Infect Dis. 2008 Jan 15;197(2):328
-
Focosi
D, Cecconi N, Boni G, Orciuolo E, Galimberti S, Petrini M. Acute myeloid
leukaemia after treatment with 90Y-ibritumomab tiuxetan for follicular
lymphoma. Haematol Oncol 2008. In press
-
Focosi
D. Treatment for elderly patients with multiple myeloma. Lancet. 2008 Mar
22;371(9617):983-4
-
Focosi
D, Kast RE, Galimberti S, Petrini M. Conditioning response to granulocyte
colony-stimulating factor via the dipeptidyl peptidase IV-adenosine deaminase
complex. J Leukoc Biol. 2008 84(2):331-7
-
Focosi
D, Kast RE, Metelli MR, Benedetti E, Galimberti S, Papineschi F, Petrini M.
Enhancement of hematopoietic stem cell engraftment by inhibition of CXCL12
proteolysis with sitagliptin, an oral dipeptidyl-peptidase IV inhibitor: A
report in a case of delayed graft failure. Leuk Res. 2008 33(1):178-81
-
Focosi
D, Kast RE, Maggi F, Ceccherini-Nelli L, Petrini M. Sialic acid moieties and
5-HT(2a): two faces of the same receptor for JC virus ? J Clin Virol. 2008
43(1):132-133
-
Focosi
D, Benedetti E, Maggi F, Papineschi F, Galimberti S, Ceccherini-Nelli L,
Petrini M. Preemptive valganciclovir for cytomegalovirus infection in
hematological patients. Transpl Inf Dis 2008 10(5):375-376
-
Focosi
D. Smartphone utilities for infectious diseases specialists. Clin Infect Dis
2008 47(9):1234-5
-
Focosi
D, Azzarà A, Kast R, Carulli G, Petrini M. Lithium and hematology: established
and proposed uses. J Leukoc Biol 2008 85(1):20-8
-
Focosi
D, Maggi F, Pistolesi D, Benedetti E, Papineschi F, Galimberti S,
Ceccherini-Nelli L, Petrini M. Hyperbaric oxygen therapy in BKV-associated
hemorrhagic cytitis refractory to intravenous and intravesical cidofovir : case
report and review of the literature. Leuk Res. 2009 33(4):556-560
-
Focosi
D, Kast RE, Maggi F, Ceccherini-Nelli L, Petrini M. Lymphotropic polyomavirus
and progressive multifocal leukoencephalopathy. J Clin Microbiol 2009;47(1):284
-
Focosi
D, Maggi F, Ceccherini-Nelli L, Marchi S, Petrini M. Progressive multifocal
leukoencephalopathy in autoimmune disorders. Gut 2009;58(4):605
-
Focosi
D, Pelosini M, Palla P, Galimberti S, Caracciolo F, Benedetti E, et al.
Hypercytokinemia-induced metabolic encephalopathy in a multiple myeloma patient
on hemodialysis undergoing autologous hematopoietic stem cell transplantation:
Clinical response after plasma exchange. Transpl Immunol 2009
-
Focosi
D, Sordi E, Papineschi F, Benedetti E, Galimberti S, Petrini M. Fatal ongoing
human cytomegalovirus reactivation during high-dose melphalan and autologous
stem cell transplantation. J Med Virol 2009;81(5):857-60
-
Focosi
D. Does contrast enhancement predict survival in progressive multifocal
leukoencephalopathy? J Infect Dis 2009 199(9):1410-1
-
Focosi
D, Kast R, Maggi FC-N, L, Petrini M. JC virus DNA in healthy brain tissue: A
challenge for progressive multifocal leukoencephalopathy diagnosis. Ann Neurol
2009 65(2):230
-
Focosi
D, Maggi F, Andreoli E, Lanini L, Ceccherini-Nelli L, Petrini M. The role of
bone marrow cells for JCV pathogenicity. J Clin Virol 2009 45(3):230-1
-
Focosi
D, Maggi F, Andreoli E, Lanini L, Ceccherini-Nelli L, Petrini M. Polyomaviruses
other than JCV are not detected in progressive multifocal leukoencephalopathy.
J Clin Virol 2009 45(2):161-2
-
Focosi
D. Bortezomib: the subtle line between drug-induced peripheral neuropathy and
post-herpetic neuralgia. Clin Lymphoma Myeloma. 2009 Aug;9(4):E16-7
-
Focosi
D, Bestagno M, Burrone O, Petrini M. CD57+ T lymphocytes and functional immune
deficiency. J Leukoc Biol. 2010 Jan;87(1):107-16
-
Focosi
D, Maggi F, Albani M, Macera L, Ricci V, Gragnani S, Di Beo S, Ghimenti M,
Antonelli G, Bendinelli M, Pistello M, Ceccherini-Nelli L, Petrini M.
Torquetenovirus viremia kinetics after autologous stem cell transplantation are
predictable and may serve as a surrogate marker of functional immune
reconstitution. J Clin Virol. 2010 Feb;47(2):189-92